Clinical Trials Browser

Terminated × perifosine × Clear all

NCT01002248 2018-02-09

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

Phase 3 Terminated

Multiple Myeloma

NCT00058214 2015-02-23

Perifosine in Treating Patients With Recurrent Prostate Cancer

Phase 2 Terminated

25 enrolled 5 charts

Prostatic Neoplasms

NCT00062387 2013-06-03

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Phase 2 Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms